Back

Novel Representations of Vaccine Protection Against Progression to Severe Disease Over Time

Dean, N.; Zarnitsyna, V.

2026-02-14 epidemiology
10.64898/2026.02.12.26346197 medRxiv
Show abstract

BackgroundVaccines can prevent severe disease by preventing infection or by reducing progression among those who become infected. Vaccine effectiveness against progression given infection is often used to quantify this second mechanism, but it conditions on infection, which is itself affected by vaccination. As a result, this estimand lacks a clear causal interpretation and may behave non-intuitively over time. MethodsWe introduce a conceptual framework that models protection against infection and protection against progression as separate components that wane over time. Protection is represented using individual-level threshold-crossing times that depend on covariates and define a time-varying population susceptible to infection. Within this framework, we derive standard vaccine effectiveness estimands and propose two alternative decompositions of protection against severe disease: a progression-risk-weighted multiplicative decomposition and an additive decomposition based on absolute risk reduction. We illustrate their behavior using simulated examples. ResultsThe weighted multiplicative decomposition restores a causal interpretation for progression protection within the doomed principal stratum and avoids negative estimates. The additive decomposition provides a clear representation of the pathways over time. ConclusionsExplicitly modeling the infection-to-severe-disease pathway improves interpretation of vaccine effectiveness under waning immunity.

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

1
American Journal of Epidemiology
57 papers in training set
Top 0.1%
18.4%
2
Epidemiology
26 papers in training set
Top 0.1%
17.3%
3
BMC Medicine
163 papers in training set
Top 0.1%
12.2%
4
Vaccine
189 papers in training set
Top 0.4%
10.0%
50% of probability mass above
5
PLOS Computational Biology
1633 papers in training set
Top 6%
6.2%
6
Journal of The Royal Society Interface
189 papers in training set
Top 2%
2.7%
7
International Journal of Epidemiology
74 papers in training set
Top 0.8%
2.6%
8
Clinical Infectious Diseases
231 papers in training set
Top 2%
2.3%
9
Vaccines
196 papers in training set
Top 1.0%
2.1%
10
PLOS ONE
4510 papers in training set
Top 49%
2.1%
11
Scientific Reports
3102 papers in training set
Top 54%
1.9%
12
Nature Communications
4913 papers in training set
Top 54%
1.5%
13
BMC Public Health
147 papers in training set
Top 4%
1.3%
14
BMC Infectious Diseases
118 papers in training set
Top 4%
1.3%
15
Epidemics
104 papers in training set
Top 1%
1.2%
16
The Journal of Infectious Diseases
182 papers in training set
Top 4%
1.2%
17
BMC Medical Research Methodology
43 papers in training set
Top 1%
0.9%
18
Epidemiology and Infection
84 papers in training set
Top 3%
0.9%
19
The Lancet Infectious Diseases
71 papers in training set
Top 3%
0.8%
20
International Journal of Infectious Diseases
126 papers in training set
Top 4%
0.7%
21
BMJ
49 papers in training set
Top 1%
0.6%
22
BMJ Global Health
98 papers in training set
Top 3%
0.6%
23
Statistics in Medicine
34 papers in training set
Top 0.4%
0.6%